The Therapeutic Application of Melatonin in Supportive Care and Palliative Medicine, Mahmoud, Sarhill & Mazurczak, Am. J. Hosp.
Palliat. Care 2005; 22: 295-309.
Melatonin – Monograph, Alt. Med. Rev. 2005; Vol. 10, No. 4: 326-336.
Melatonin Provokes
Cell Death in Human B-Lymphoma Cells by Mitochondria-dependent Apoptotic Pathway Activation, Trubiani, Recchioni, Moroni, et al.,J. Pineal Res. 2005; 39 (4): 425-431.
Melatonin Induces Apoptosis in Human Neuroblastoma Cancer Cells, Garcia-Santos, Antolin,
Herrara, et al., J. Pineal Res. 2006; 41 (2): 130-135.
Increased Survival Time in Brain Glioblastoma by a Radio-neuro-endocrine
Strategy with Radiotherapy Plus Melatonin Compared to Radiotherapy Alone, Lissoni, Meregalli, Nosetto, et al., Oncology 1996; 53:
43-46.
Five-Years Survival in Metastatic Non-Small Cell Lung Cancer Patients Treated with Chemotherapy Alone or Chemotherapy
with Melatonin: A Randomized Trial, Lissoni, et al., J. Pineal Res. 2003; 35 (1): 12-15.
Circadian Function in Patients with
Advanced Non-small-cell Lung Cancer, Levin, Daehler, Grutsch, et al., Br. J. Cancer 2005; 93 (11): 1202-1208.
Light at Night
Co-distributes with Incident Breast But Not Lung Cancer in the Female Population of
Global Co-distribution of Light at Night (LAN) and Cancers of Prostate, Colon, and Lung in Men, Kloog
, Haim, Stevens & Portnov, Chronobiol Int. 2009; 26 (1): 108-125.
Aromatase Inhibitor-induced Joint Pain: Melatonin’s
Role, Burk, Med. Hypoth. 2008; doi: 10.1016/j.mehy.2008.07.040.
Randomized Study with the Pineal Hormone Melatonin versus
Supportive Care Alone in Advanced Non-small-cell Lung Cancer Resistant to a First-line Chemotherapy Containing Cisplatin, Lissoni,
Barni, Ardizzoia, et al., Oncology 1992; 49 (5): 336-339.
Neuro-immunotherapy of Untreatable Metastatic Solid Tumors with Subcutaneous
Low-dose Interleukin-2, Melatonin and Naltrexone: Modulation of interleukin-2-induced Anti-tumor Immunity by Blocking the Opioid System, Lissoni,
Malugani, Malysheva, et al., Neuro. Endocrinol. Lett. 2002; 23 (4): 341-344.
Melatonin in Human Breast Cancer Tissue: Association
with Nuclear Grade and Estrogen Receptor Status, Maestroni & Conti, Lab. Inv.1996; 75 (4): 557-561.
Immune and Endocrine
Mechanisms of Advanced Cancer-related Hypercortisolemia, Lissoni, Brivio, Fumagalli, et al., In Vivo 2007; 21 (4): 647-650.
Melatonin Increase as Predictor for Tumor Objective Response to Chemotherapy in Advanced Cancer Patients, Lissoni, Tancini,
Barni, et al., Tumori 1998; 74 (3): 339-345.
Chronotherapy for Cancer, Eriguchi, Levi, Hisa, et al., Biomed. Pharmacother. 2003;
57 Suppl 1: 92s-95s.
Biomodulation of Cancer Chemotherapy for Metastatic Colorectal Cancer: A Randomized Study of Weekly Low-dose
Irinotecan Alone versus Irinotecan Plus the Oncostatic Pineal Hormone Melatonin in Metastatic Colorectal Cancer Patients Progressing
on 5-fluorouracil-containing Combinations, Cerea, Vagh, Ardizzoia, et al., Anticancer Res. 2003; 23 (2C): 1951-1954.
Melatonin
in Clinical Oncology, Bartsch, Bartsch & Karasek, Neuro. Endocrinol. Lett. 2002; 23 Suppl 1: 30-
Melatonin: Fifty Years of
Scientific Journey from the Discovery in Bovine Pineal Gland to Delineation of Functions in Human, Chowdhury, Sengupta & Maitra,Indian J Biochem Biophys. 2008; 45 (5): 289-304.
The Immune-Pineal Axis: Stress as a Modulator of Pineal Gland Function, Couto-Moraes,
Palermo-Neto & Markus, Ann N Y Acad Sci. 2009; 1153: 193-202.
A Review of the Evidence Supporting Melatonin's Role
as an Antioxidant, Reiter, Melchiorri, Sewerynek, et al., J Pineal Res. 1995; 18 (1): 1-11.
Health Disorders of
Shift Workers, Knutsson, Occup Med (Lond). 2003; 53 (2): 103-108.
Night-shift Work and Risk of Colorectal Cancer in the Nurses' Health Study, Schernhammer, Laden, Speizer, et al., J. Natl. Cancer Inst. 2003; 95 (11): 825-828